Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
Kedudukan dalam Saham
#4950
Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally... Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally focusing on the production and distribution of a broad spectrum of pharmaceutical goods. Its product line encompasses various drug forms like oral liquids, injections, capsules, granules, pills, and tablets, as well as traditional Chinese herbal medicines, powders, syrups, and spirits. The company also produces specialized medicinal products, including enzymes, biochemical drugs, and plant-based chemical medicines. In addition to its core pharmaceutical activities, Jilin Aodong diversifies its operations across several other sectors. These include highway construction and toll management, animal husbandry, the creation of specialty chemicals, and the provision of heat and water. The company further engages in the wholesale, retail, and distribution of medicines, packaging design and printing, the manufacturing of medicinal packaging materials, and delivers information consulting and advertising design solutions. Founded in 1957, its corporate headquarters are situated in Dunhua, China.
Harga Saham
$2.47
Modal Pasaran
$2.95B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-14.68%
Negara
CN
Perdagangan Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Kategori
Healthcare
Bilangan saham terbitan bagi Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Bilangan saham terbitan setakat June 2026: 1.17B
Menurut laporan kewangan terkini dan harga saham Jilin Aodong Pharmaceutical Group Co., Ltd., bilangan saham terbitan semasa ialah 1.17B. Pada akhir December 2023, syarikat mempunyai 1.13B saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Jilin Aodong Pharmaceutical Group Co., Ltd. (000623) dari 2000 hingga 2026
Saham terbitan pada akhir setiap tahun
| Tahun | Saham Terbitan | Ubah |
|---|---|---|
| 2026 (TTM) | 1.17B | -0.40% |
| 2024 | 1.18B | 4.59% |
| 2023 | 1.13B | -0.81% |
| 2022 | 1.13B | -0.41% |
| 2021 | 1.14B | -1.63% |
| 2020 | 1.16B | -0.40% |
| 2019 | 1.16B | 0.02% |
| 2018 | 1.16B | 0.00% |
| 2017 | 1.16B | 1.31% |
| 2016 | 1.15B | -1.28% |
| 2015 | 1.16B | 0.17% |
| 2014 | 1.16B | -0.49% |
| 2013 | 1.17B | -0.06% |
| 2012 | 1.17B | 0.56% |
| 2011 | 1.16B | -0.12% |
| 2010 | 1.16B | -0.20% |
| 2009 | 1.16B | -0.04% |
| 2008 | 1.16B | 0.05% |
| 2007 | 1.16B | 0.20% |
| 2006 | 1.16B | -0.20% |
| 2005 | 1.16B | 0.00% |
| 2004 | 1.16B | 0.00% |
| 2003 | 1.16B | 0.00% |
| 2002 | 1.16B | 0.00% |
| 2001 | 1.16B | 0.00% |
| 2000 | 1.16B | 0.00% |
Saham terbitan bagi syarikat atau pesaing yang serupa
| Syarikat | Saham Terbitan | Perbezaan | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 104.65% |
IN
|
